| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Damage | 27 | 2021 | 1954 | 2.470 |
Why?
|
| DNA Repair | 20 | 2021 | 1872 | 2.010 |
Why?
|
| Nerve Tissue Proteins | 12 | 2013 | 1491 | 1.850 |
Why?
|
| BRCA1 Protein | 12 | 2023 | 493 | 1.510 |
Why?
|
| Tumor Suppressor Proteins | 8 | 2014 | 1823 | 1.190 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 7 | 2019 | 479 | 1.190 |
Why?
|
| Recombinational DNA Repair | 4 | 2018 | 79 | 1.130 |
Why?
|
| Chromatin Assembly and Disassembly | 4 | 2013 | 287 | 0.980 |
Why?
|
| DNA Breaks, Double-Stranded | 8 | 2015 | 316 | 0.970 |
Why?
|
| Cytoskeletal Proteins | 15 | 2014 | 492 | 0.960 |
Why?
|
| Homologous Recombination | 8 | 2023 | 185 | 0.940 |
Why?
|
| Cell Cycle Proteins | 21 | 2021 | 2045 | 0.930 |
Why?
|
| PTEN Phosphohydrolase | 4 | 2015 | 986 | 0.900 |
Why?
|
| Neoplasms | 16 | 2024 | 15193 | 0.880 |
Why?
|
| Genes, Tumor Suppressor | 4 | 2014 | 1064 | 0.830 |
Why?
|
| Genomic Instability | 7 | 2020 | 519 | 0.820 |
Why?
|
| Ecosystem | 1 | 2022 | 111 | 0.810 |
Why?
|
| DNA Replication | 3 | 2018 | 744 | 0.810 |
Why?
|
| Triple Negative Breast Neoplasms | 3 | 2023 | 1215 | 0.810 |
Why?
|
| Chromosomal Proteins, Non-Histone | 6 | 2015 | 362 | 0.730 |
Why?
|
| Cyclopentanes | 1 | 2020 | 40 | 0.730 |
Why?
|
| Histones | 6 | 2015 | 1466 | 0.700 |
Why?
|
| Ubiquitination | 6 | 2014 | 575 | 0.700 |
Why?
|
| DNA Mismatch Repair | 1 | 2020 | 268 | 0.630 |
Why?
|
| Protein-Tyrosine Kinases | 4 | 2021 | 1756 | 0.620 |
Why?
|
| Gene Expression Profiling | 4 | 2022 | 5159 | 0.580 |
Why?
|
| Breast Neoplasms | 19 | 2023 | 15694 | 0.580 |
Why?
|
| Nuclear Proteins | 11 | 2020 | 3343 | 0.570 |
Why?
|
| Cell Line, Tumor | 21 | 2021 | 14551 | 0.550 |
Why?
|
| Proteome | 1 | 2020 | 561 | 0.550 |
Why?
|
| Phthalazines | 3 | 2018 | 253 | 0.520 |
Why?
|
| Trans-Activators | 5 | 2011 | 1555 | 0.510 |
Why?
|
| Heterochromatin | 1 | 2015 | 83 | 0.500 |
Why?
|
| Cell Transformation, Neoplastic | 6 | 2014 | 2359 | 0.500 |
Why?
|
| Stress, Physiological | 1 | 2018 | 492 | 0.500 |
Why?
|
| Methyltransferases | 1 | 2015 | 148 | 0.490 |
Why?
|
| Carcinoma, Adenoid Cystic | 3 | 2023 | 421 | 0.490 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2024 | 3552 | 0.480 |
Why?
|
| Gene Expression Regulation, Neoplastic | 10 | 2021 | 8873 | 0.480 |
Why?
|
| Animals | 40 | 2023 | 59536 | 0.450 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2015 | 803 | 0.430 |
Why?
|
| Mice | 29 | 2023 | 34495 | 0.430 |
Why?
|
| Poly Adenosine Diphosphate Ribose | 1 | 2012 | 11 | 0.420 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2012 | 28 | 0.420 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 3 | 2023 | 992 | 0.420 |
Why?
|
| Transcription Factors | 9 | 2020 | 5270 | 0.410 |
Why?
|
| Repressor Proteins | 3 | 2015 | 1664 | 0.400 |
Why?
|
| Histone Acetyltransferases | 1 | 2013 | 411 | 0.390 |
Why?
|
| Humans | 72 | 2024 | 261506 | 0.390 |
Why?
|
| Cell Cycle | 6 | 2021 | 2084 | 0.390 |
Why?
|
| RNA, Small Interfering | 8 | 2015 | 2216 | 0.380 |
Why?
|
| Zinc Fingers | 1 | 2011 | 205 | 0.380 |
Why?
|
| Autoantigens | 1 | 2012 | 234 | 0.370 |
Why?
|
| Endometrial Neoplasms | 1 | 2020 | 1341 | 0.370 |
Why?
|
| DNA Helicases | 2 | 2012 | 434 | 0.370 |
Why?
|
| Neoplasm Proteins | 5 | 2017 | 3230 | 0.360 |
Why?
|
| Neoplastic Stem Cells | 1 | 2018 | 1443 | 0.360 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2021 | 4757 | 0.360 |
Why?
|
| Centrosome | 2 | 2014 | 95 | 0.350 |
Why?
|
| Cell Division | 2 | 2004 | 2489 | 0.350 |
Why?
|
| Antigens | 2 | 2021 | 292 | 0.330 |
Why?
|
| DNA-Binding Proteins | 10 | 2020 | 4821 | 0.330 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2015 | 1546 | 0.330 |
Why?
|
| Cell Survival | 7 | 2021 | 3045 | 0.330 |
Why?
|
| Carrier Proteins | 4 | 2019 | 2022 | 0.330 |
Why?
|
| Signal Transduction | 10 | 2019 | 11965 | 0.330 |
Why?
|
| Rad51 Recombinase | 3 | 2021 | 126 | 0.320 |
Why?
|
| Immunity, Innate | 2 | 2023 | 677 | 0.320 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2017 | 2488 | 0.320 |
Why?
|
| GTP-Binding Proteins | 2 | 2020 | 321 | 0.310 |
Why?
|
| Genetic Linkage | 1 | 2009 | 512 | 0.310 |
Why?
|
| Retinoblastoma Protein | 1 | 2009 | 335 | 0.310 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2009 | 311 | 0.310 |
Why?
|
| Salivary Gland Neoplasms | 2 | 2023 | 489 | 0.310 |
Why?
|
| Poly(ADP-ribose) Polymerases | 4 | 2018 | 324 | 0.300 |
Why?
|
| Genome | 4 | 2022 | 672 | 0.300 |
Why?
|
| Pyrimidines | 1 | 2020 | 3518 | 0.300 |
Why?
|
| Mitosis | 5 | 2019 | 615 | 0.290 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 3 | 2018 | 507 | 0.290 |
Why?
|
| Aging | 2 | 2016 | 1582 | 0.280 |
Why?
|
| src-Family Kinases | 1 | 2009 | 478 | 0.280 |
Why?
|
| Phosphorylation | 10 | 2020 | 4804 | 0.280 |
Why?
|
| Protein Stability | 2 | 2020 | 370 | 0.270 |
Why?
|
| Cell Line | 7 | 2015 | 5114 | 0.270 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2018 | 371 | 0.260 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2011 | 1439 | 0.260 |
Why?
|
| Protein Kinases | 3 | 2006 | 874 | 0.260 |
Why?
|
| Replication Protein A | 3 | 2013 | 35 | 0.250 |
Why?
|
| Tumor Microenvironment | 4 | 2024 | 2864 | 0.250 |
Why?
|
| Telomere | 2 | 2009 | 505 | 0.250 |
Why?
|
| RNA Interference | 5 | 2015 | 1408 | 0.250 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2021 | 3821 | 0.240 |
Why?
|
| Piperazines | 2 | 2018 | 2101 | 0.240 |
Why?
|
| Biomarkers, Tumor | 7 | 2023 | 10331 | 0.240 |
Why?
|
| Programmed Cell Death 1 Receptor | 2 | 2021 | 1048 | 0.230 |
Why?
|
| Mice, Nude | 8 | 2019 | 4307 | 0.230 |
Why?
|
| Eukaryotic Cells | 1 | 2003 | 45 | 0.230 |
Why?
|
| Xenopus Proteins | 1 | 2004 | 185 | 0.230 |
Why?
|
| Carcinoma, Acinar Cell | 1 | 2023 | 84 | 0.230 |
Why?
|
| Female | 29 | 2023 | 141928 | 0.220 |
Why?
|
| Genome, Human | 2 | 2020 | 1869 | 0.220 |
Why?
|
| Chromatin | 5 | 2013 | 942 | 0.220 |
Why?
|
| Microcephaly | 1 | 2005 | 325 | 0.210 |
Why?
|
| Carcinoma, Mucoepidermoid | 1 | 2023 | 137 | 0.210 |
Why?
|
| DNA | 3 | 2024 | 2693 | 0.210 |
Why?
|
| Myoepithelioma | 1 | 2022 | 31 | 0.210 |
Why?
|
| Breast | 4 | 2012 | 1344 | 0.210 |
Why?
|
| Drug Synergism | 4 | 2021 | 1313 | 0.210 |
Why?
|
| Cell Proliferation | 7 | 2019 | 7226 | 0.200 |
Why?
|
| BRCA2 Protein | 3 | 2023 | 358 | 0.200 |
Why?
|
| Tumor Necrosis Factor Receptor Superfamily, Member 9 | 1 | 2022 | 69 | 0.200 |
Why?
|
| Alarmins | 1 | 2021 | 10 | 0.200 |
Why?
|
| Immunogenicity, Vaccine | 1 | 2022 | 86 | 0.200 |
Why?
|
| CD3 Complex | 1 | 2022 | 314 | 0.190 |
Why?
|
| Parotid Neoplasms | 1 | 2022 | 148 | 0.190 |
Why?
|
| HCT116 Cells | 2 | 2020 | 348 | 0.190 |
Why?
|
| Immunoprecipitation | 2 | 2015 | 591 | 0.190 |
Why?
|
| Immunotherapy | 4 | 2022 | 3341 | 0.190 |
Why?
|
| Mice, Transgenic | 5 | 2020 | 4143 | 0.190 |
Why?
|
| Chromosome Aberrations | 2 | 2014 | 1960 | 0.190 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2023 | 368 | 0.190 |
Why?
|
| Epidermal Growth Factor | 2 | 2001 | 423 | 0.190 |
Why?
|
| NEDD8 Protein | 1 | 2020 | 22 | 0.190 |
Why?
|
| Mutation | 10 | 2020 | 15179 | 0.180 |
Why?
|
| Genomics | 3 | 2022 | 2738 | 0.180 |
Why?
|
| Gene Dosage | 2 | 2018 | 829 | 0.180 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 4 | 2018 | 430 | 0.180 |
Why?
|
| Telomerase | 1 | 2003 | 525 | 0.180 |
Why?
|
| Models, Biological | 3 | 2018 | 3254 | 0.180 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2011 | 1265 | 0.170 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2022 | 5319 | 0.170 |
Why?
|
| Sp1 Transcription Factor | 2 | 1999 | 188 | 0.170 |
Why?
|
| Ligands | 2 | 2021 | 995 | 0.170 |
Why?
|
| Protein Structure, Tertiary | 2 | 2015 | 1487 | 0.170 |
Why?
|
| Cellular Senescence | 2 | 2018 | 382 | 0.170 |
Why?
|
| Cell Death | 1 | 2021 | 671 | 0.160 |
Why?
|
| Lung Neoplasms | 4 | 2022 | 11538 | 0.160 |
Why?
|
| Interleukin-2 | 1 | 2022 | 842 | 0.160 |
Why?
|
| Molecular Sequence Data | 5 | 2015 | 6089 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 3 | 2020 | 6942 | 0.160 |
Why?
|
| Cell Membrane | 1 | 2001 | 850 | 0.160 |
Why?
|
| Microsatellite Instability | 1 | 2020 | 400 | 0.160 |
Why?
|
| Cyclin D1 | 1 | 2000 | 576 | 0.150 |
Why?
|
| Protein Binding | 5 | 2015 | 3438 | 0.150 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 3 | 2017 | 170 | 0.150 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2019 | 494 | 0.150 |
Why?
|
| ErbB Receptors | 3 | 2015 | 2295 | 0.150 |
Why?
|
| Protein Interaction Mapping | 2 | 2009 | 162 | 0.150 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2013 | 854 | 0.150 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2019 | 221 | 0.150 |
Why?
|
| CTLA-4 Antigen | 1 | 2021 | 657 | 0.150 |
Why?
|
| MCF-7 Cells | 1 | 2018 | 550 | 0.140 |
Why?
|
| MAP Kinase Signaling System | 2 | 2017 | 848 | 0.140 |
Why?
|
| Protein Transport | 3 | 2015 | 734 | 0.140 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2018 | 460 | 0.140 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2017 | 196 | 0.140 |
Why?
|
| Fumarates | 1 | 2015 | 30 | 0.130 |
Why?
|
| Cell Nucleus | 2 | 2015 | 1620 | 0.130 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2020 | 5178 | 0.130 |
Why?
|
| Apoptosis | 7 | 2021 | 7591 | 0.130 |
Why?
|
| Checkpoint Kinase 1 | 2 | 2006 | 174 | 0.130 |
Why?
|
| Cyclin E | 2 | 2010 | 267 | 0.130 |
Why?
|
| Checkpoint Kinase 2 | 2 | 2015 | 126 | 0.130 |
Why?
|
| Down-Regulation | 3 | 2017 | 2074 | 0.130 |
Why?
|
| Chromones | 1 | 2015 | 120 | 0.130 |
Why?
|
| Transcriptome | 2 | 2020 | 1859 | 0.130 |
Why?
|
| Oncogenes | 1 | 2018 | 673 | 0.130 |
Why?
|
| Disease Progression | 4 | 2014 | 6682 | 0.120 |
Why?
|
| Reproducibility of Results | 2 | 2023 | 6009 | 0.120 |
Why?
|
| Alternative Splicing | 1 | 2017 | 584 | 0.120 |
Why?
|
| Tyrosine | 2 | 2015 | 498 | 0.120 |
Why?
|
| Genes, ras | 1 | 2017 | 667 | 0.120 |
Why?
|
| Epithelial Cells | 1 | 2001 | 1818 | 0.120 |
Why?
|
| NF-kappa B | 4 | 2024 | 1549 | 0.120 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2020 | 15862 | 0.120 |
Why?
|
| Lysine Acetyltransferase 5 | 1 | 2013 | 17 | 0.120 |
Why?
|
| Base Sequence | 3 | 2006 | 4917 | 0.110 |
Why?
|
| Morpholines | 1 | 2015 | 289 | 0.110 |
Why?
|
| Homeodomain Proteins | 2 | 2012 | 1143 | 0.110 |
Why?
|
| Amino Acid Sequence | 4 | 2015 | 4233 | 0.110 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2017 | 661 | 0.110 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2013 | 195 | 0.110 |
Why?
|
| Deoxycytidine | 1 | 2018 | 1353 | 0.110 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 2012 | 116 | 0.110 |
Why?
|
| Salivary Glands | 2 | 2023 | 130 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 6 | 2019 | 5395 | 0.100 |
Why?
|
| Acetylation | 1 | 2013 | 508 | 0.100 |
Why?
|
| Carcinoma | 1 | 2023 | 2578 | 0.100 |
Why?
|
| Mice, Knockout | 4 | 2020 | 5710 | 0.100 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2017 | 833 | 0.100 |
Why?
|
| CDC2 Protein Kinase | 1 | 2011 | 176 | 0.100 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2011 | 89 | 0.100 |
Why?
|
| Disease Models, Animal | 4 | 2021 | 7222 | 0.100 |
Why?
|
| Anthracyclines | 1 | 2012 | 331 | 0.100 |
Why?
|
| Phenotype | 3 | 2018 | 6295 | 0.090 |
Why?
|
| Radiation, Ionizing | 2 | 2015 | 187 | 0.090 |
Why?
|
| HeLa Cells | 5 | 2015 | 1643 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2000 | 1538 | 0.090 |
Why?
|
| Chloride Channels | 1 | 2010 | 60 | 0.090 |
Why?
|
| Nucleotidyltransferases | 2 | 2024 | 82 | 0.090 |
Why?
|
| Chromatography, Affinity | 1 | 2009 | 122 | 0.090 |
Why?
|
| Telomeric Repeat Binding Protein 2 | 1 | 2009 | 25 | 0.090 |
Why?
|
| Nedd4 Ubiquitin Protein Ligases | 1 | 2009 | 23 | 0.090 |
Why?
|
| Drosophila Proteins | 1 | 1996 | 858 | 0.090 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 644 | 0.090 |
Why?
|
| Cells, Cultured | 3 | 2021 | 5637 | 0.090 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2009 | 60 | 0.090 |
Why?
|
| Meiosis | 1 | 2010 | 166 | 0.090 |
Why?
|
| Algorithms | 1 | 2020 | 3890 | 0.080 |
Why?
|
| Transfection | 5 | 2003 | 2944 | 0.080 |
Why?
|
| Peptide Hydrolases | 1 | 2010 | 256 | 0.080 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2020 | 2027 | 0.080 |
Why?
|
| RNA-Binding Proteins | 3 | 2023 | 984 | 0.080 |
Why?
|
| Cytokinesis | 1 | 2008 | 57 | 0.080 |
Why?
|
| Spindle Apparatus | 1 | 2008 | 93 | 0.080 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2015 | 1678 | 0.080 |
Why?
|
| Aurora Kinases | 1 | 2008 | 189 | 0.080 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 3869 | 0.080 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2009 | 518 | 0.080 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2009 | 280 | 0.080 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2020 | 2326 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2012 | 778 | 0.080 |
Why?
|
| Immunoblotting | 1 | 2009 | 886 | 0.080 |
Why?
|
| Cell Movement | 2 | 2018 | 2466 | 0.080 |
Why?
|
| Recombination, Genetic | 1 | 2010 | 613 | 0.070 |
Why?
|
| Flow Cytometry | 1 | 2014 | 3033 | 0.070 |
Why?
|
| Quality of Life | 1 | 2021 | 4532 | 0.070 |
Why?
|
| Prognosis | 6 | 2023 | 21713 | 0.070 |
Why?
|
| Kidney Neoplasms | 1 | 2020 | 3022 | 0.070 |
Why?
|
| Stem Cells | 1 | 2013 | 1213 | 0.070 |
Why?
|
| Antigens, Neoplasm | 1 | 2012 | 1506 | 0.070 |
Why?
|
| Phosphoproteins | 2 | 2003 | 1152 | 0.070 |
Why?
|
| Lymphoma | 1 | 2014 | 1467 | 0.070 |
Why?
|
| Retroviridae | 1 | 2006 | 332 | 0.070 |
Why?
|
| Mutation, Missense | 1 | 2011 | 1152 | 0.070 |
Why?
|
| Software | 2 | 2022 | 1321 | 0.060 |
Why?
|
| Gene Regulatory Networks | 2 | 2020 | 677 | 0.060 |
Why?
|
| Oligoribonucleotides | 1 | 2004 | 10 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 1996 | 4053 | 0.060 |
Why?
|
| Colorectal Neoplasms | 1 | 2020 | 3578 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 2 | 2010 | 3981 | 0.060 |
Why?
|
| V-Set Domain-Containing T-Cell Activation Inhibitor 1 | 1 | 2023 | 29 | 0.060 |
Why?
|
| Zinc Finger E-box Binding Homeobox 2 | 1 | 2003 | 42 | 0.060 |
Why?
|
| Genome-Wide Association Study | 2 | 2023 | 2265 | 0.060 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2003 | 110 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2009 | 3536 | 0.060 |
Why?
|
| Cell Line, Transformed | 1 | 2003 | 394 | 0.060 |
Why?
|
| Chromosomal Instability | 1 | 2024 | 233 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 3639 | 0.050 |
Why?
|
| Transplantation, Heterologous | 3 | 2012 | 1082 | 0.050 |
Why?
|
| Interferons | 1 | 2024 | 291 | 0.050 |
Why?
|
| Syndrome | 1 | 2005 | 1351 | 0.050 |
Why?
|
| Ovarian Neoplasms | 4 | 2018 | 4638 | 0.050 |
Why?
|
| Osteosarcoma | 1 | 2009 | 929 | 0.050 |
Why?
|
| Chromatography, Liquid | 1 | 2023 | 342 | 0.050 |
Why?
|
| Consensus Sequence | 1 | 2001 | 117 | 0.050 |
Why?
|
| Colonic Neoplasms | 1 | 2010 | 1390 | 0.050 |
Why?
|
| Kinetics | 2 | 2001 | 2049 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2006 | 2054 | 0.050 |
Why?
|
| Age Factors | 1 | 2010 | 5377 | 0.050 |
Why?
|
| Antineoplastic Agents | 2 | 2021 | 14289 | 0.050 |
Why?
|
| Neoplasm Transplantation | 2 | 2017 | 1519 | 0.050 |
Why?
|
| Antigen-Antibody Complex | 1 | 2020 | 115 | 0.050 |
Why?
|
| Up-Regulation | 2 | 2020 | 2450 | 0.050 |
Why?
|
| Proteogenomics | 1 | 2020 | 87 | 0.050 |
Why?
|
| Cluster Analysis | 1 | 2022 | 1053 | 0.040 |
Why?
|
| STAT1 Transcription Factor | 1 | 2020 | 156 | 0.040 |
Why?
|
| G2 Phase Cell Cycle Checkpoints | 1 | 2019 | 76 | 0.040 |
Why?
|
| Pyrimidinones | 1 | 2021 | 314 | 0.040 |
Why?
|
| ras Proteins | 1 | 2003 | 770 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2009 | 6150 | 0.040 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2021 | 363 | 0.040 |
Why?
|
| Adenovirus E1A Proteins | 1 | 1999 | 163 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 2 | 2020 | 2314 | 0.040 |
Why?
|
| Tissue Array Analysis | 1 | 2020 | 760 | 0.040 |
Why?
|
| Hydroxyurea | 1 | 2019 | 204 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2020 | 1062 | 0.040 |
Why?
|
| Transplantation, Isogeneic | 1 | 2017 | 56 | 0.040 |
Why?
|
| Copper Radioisotopes | 1 | 2017 | 31 | 0.040 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2017 | 113 | 0.040 |
Why?
|
| Lactams, Macrocyclic | 1 | 2017 | 90 | 0.040 |
Why?
|
| Binding Sites | 1 | 2001 | 2171 | 0.040 |
Why?
|
| Tumor Suppressor p53-Binding Protein 1 | 2 | 2011 | 87 | 0.040 |
Why?
|
| Benzoquinones | 1 | 2017 | 108 | 0.040 |
Why?
|
| Heterografts | 1 | 2019 | 733 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2022 | 1033 | 0.040 |
Why?
|
| Uterus | 1 | 2001 | 678 | 0.040 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 1 | 1996 | 54 | 0.040 |
Why?
|
| Transcription Factor DP1 | 1 | 1996 | 57 | 0.040 |
Why?
|
| Survival Rate | 2 | 2020 | 12221 | 0.040 |
Why?
|
| Bone Neoplasms | 1 | 2009 | 2576 | 0.030 |
Why?
|
| E2F Transcription Factors | 1 | 1996 | 132 | 0.030 |
Why?
|
| beta Catenin | 1 | 2000 | 688 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2022 | 1294 | 0.030 |
Why?
|
| Fumarate Hydratase | 1 | 2015 | 13 | 0.030 |
Why?
|
| Genetic Heterogeneity | 1 | 2017 | 318 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2001 | 2927 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2018 | 769 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2022 | 1516 | 0.030 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2015 | 76 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2018 | 709 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2019 | 1869 | 0.030 |
Why?
|
| E2F1 Transcription Factor | 1 | 1996 | 206 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2003 | 1589 | 0.030 |
Why?
|
| F-Box Proteins | 1 | 2015 | 96 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2018 | 745 | 0.030 |
Why?
|
| Computational Biology | 1 | 2021 | 1271 | 0.030 |
Why?
|
| 3T3 Cells | 3 | 2000 | 355 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 1586 | 0.030 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2015 | 113 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2023 | 4971 | 0.030 |
Why?
|
| Middle Aged | 4 | 2022 | 86204 | 0.030 |
Why?
|
| Methylation | 1 | 2015 | 597 | 0.030 |
Why?
|
| Antibodies | 1 | 2017 | 838 | 0.030 |
Why?
|
| Aneuploidy | 1 | 2014 | 369 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2019 | 1987 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 3472 | 0.030 |
Why?
|
| Cross-Linking Reagents | 1 | 2013 | 153 | 0.030 |
Why?
|
| Ku Autoantigen | 1 | 2012 | 79 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 4938 | 0.030 |
Why?
|
| Internet | 1 | 2017 | 706 | 0.030 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2018 | 1016 | 0.030 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 1 | 2012 | 109 | 0.030 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2012 | 54 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2021 | 1471 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 4314 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2022 | 6100 | 0.030 |
Why?
|
| Fibroblasts | 2 | 2014 | 1682 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2011 | 34 | 0.030 |
Why?
|
| Liver Neoplasms | 3 | 2020 | 4557 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 973 | 0.020 |
Why?
|
| Plasmids | 1 | 2013 | 837 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2022 | 29902 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2010 | 7789 | 0.020 |
Why?
|
| Neoplastic Processes | 1 | 2010 | 15 | 0.020 |
Why?
|
| Proteomics | 1 | 2018 | 1380 | 0.020 |
Why?
|
| COP9 Signalosome Complex | 1 | 2010 | 72 | 0.020 |
Why?
|
| Blastocyst | 1 | 2010 | 124 | 0.020 |
Why?
|
| Receptor, ErbB-2 | 1 | 2000 | 2518 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 2330 | 0.020 |
Why?
|
| Quinazolines | 1 | 2015 | 923 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 1996 | 829 | 0.020 |
Why?
|
| DNA Repair-Deficiency Disorders | 1 | 2009 | 9 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2020 | 7548 | 0.020 |
Why?
|
| Cytokines | 1 | 2018 | 2809 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 1996 | 3101 | 0.020 |
Why?
|
| Resting Phase, Cell Cycle | 2 | 1999 | 35 | 0.020 |
Why?
|
| I-kappa B Kinase | 2 | 2000 | 250 | 0.020 |
Why?
|
| Pregnancy | 1 | 2001 | 7573 | 0.020 |
Why?
|
| Embryonic Development | 1 | 2010 | 306 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2020 | 9244 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2009 | 611 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2010 | 1213 | 0.020 |
Why?
|
| Male | 4 | 2022 | 123000 | 0.020 |
Why?
|
| Actinin | 1 | 2006 | 21 | 0.020 |
Why?
|
| Alleles | 1 | 2013 | 2437 | 0.020 |
Why?
|
| Genetic Complementation Test | 1 | 2006 | 125 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2019 | 10001 | 0.020 |
Why?
|
| Aged | 2 | 2022 | 70117 | 0.020 |
Why?
|
| Time Factors | 1 | 2019 | 12926 | 0.020 |
Why?
|
| Adult | 2 | 2020 | 77950 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2006 | 487 | 0.010 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2003 | 231 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 448 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2010 | 5112 | 0.010 |
Why?
|
| Drug Resistance | 1 | 2000 | 587 | 0.010 |
Why?
|
| G2 Phase | 1 | 1999 | 206 | 0.010 |
Why?
|
| Dimerization | 1 | 1997 | 304 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 1999 | 571 | 0.010 |
Why?
|
| G1 Phase | 1 | 1997 | 285 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2000 | 1764 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1997 | 931 | 0.010 |
Why?
|
| Gene Expression | 1 | 1997 | 3570 | 0.010 |
Why?
|
| Rats | 1 | 1997 | 6086 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 1999 | 5767 | 0.000 |
Why?
|